Clinical Trial Update: Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating radioactive iodine therapy after surgery for liver cancer; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Radioactive iodine (Iodine-131) (Iodine-131)

Snippet

Sponsor: National Medical Research Council (NMRC), Singapore | Conditions: Liver Cancer | Phase 3 | Status: UNKNOWN